Japan: medical device segment revenue 2016-2026

The revenue of the Japanese medical device market increased to over 3.1 trillion yen in 2021. Over 501 billion yen of this revenue was created by the cardiology device segment alone, making it the most profitable segment. Diagnostic imaging devices and Orthopedic devices generated around 452 billion and 419 billion yen respectively. The Statista Health Market Outlook estimates that revenue of all market segments in Japan will continue to increase.

Revenue of the medical devices market in Japan from 2016 to 2026, by segment (in billion Japanese yen)

Characteristic	Other Medical Devices	Cardiology Devices	Diagnostic Imaging Devices	Orthopedic Devices	Ophthalmic Devices	General & Plastic Surgery Devices
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

More information

Supplementary notes

The Medical Technology market segments reflect the most important markets for In Vitro Diagnostics and Medical Devices. Medical Technology vendors offer advanced medical devices from prevention to diagnosis to cure. The market is defined as products, services, or solutions used to save and improve people’s lives. This field has become an increasingly important part in healthcare over the past decade.

Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent. Company examples: Medtronic, Johnson & Johnson, Abbott Laboratories, Siemens Healthineers.

All figures are estimates. A detailed methodology can be found in the Statista Market Outlook.

Citation formats